Jan Malcolm's most recent trade in United Therapeutics Corp was a trade of 650 Restricted Stock Unit done . Disclosure was reported to the exchange on July 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Jan Malcolm | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 650 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Jan Malcolm | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 650 | 775 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Jan Malcolm | Director | Sale of securities on an exchange or to another person at price $ 550.59 per share. | 09 Jul 2026 | 325 | 450 (0%) | 0% | 550.6 | 178,942 | Common Stock |
| United Therapeutics Corp | Jan Malcolm | Director | Sale of securities on an exchange or to another person at price $ 533.51 per share. | 17 Mar 2026 | 45 | 125 (0%) | 0% | 533.5 | 24,008 | Common Stock |
| United Therapeutics Corp | Jan Malcolm | Director | Sale of securities on an exchange or to another person at price $ 509.20 per share. | 03 Mar 2026 | 50 | 170 (0%) | 0% | 509.2 | 25,460 | Common Stock |
| United Therapeutics Corp | Jan Malcolm | Director | Sale of securities on an exchange or to another person at price $ 474.68 per share. | 17 Feb 2026 | 50 | 220 (0%) | 0% | 474.7 | 23,734 | Common Stock |
| United Therapeutics Corp | Jan Malcolm | Director | Sale of securities on an exchange or to another person at price $ 474.24 per share. | 03 Feb 2026 | 50 | 270 (0%) | 0% | 474.2 | 23,712 | Common Stock |
| United Therapeutics Corp | Jan Malcolm | Director | Sale of securities on an exchange or to another person at price $ 460.98 per share. | 16 Jan 2026 | 50 | 320 (0%) | 0% | 461.0 | 23,049 | Common Stock |
| United Therapeutics Corp | Jan Malcolm | Director | Sale of securities on an exchange or to another person at price $ 495.02 per share. | 05 Jan 2026 | 50 | 370 (0%) | 0% | 495.0 | 24,751 | Common Stock |
| United Therapeutics Corp | Jan Malcolm | Director | Sale of securities on an exchange or to another person at price $ 512.12 per share. | 23 Dec 2025 | 50 | 420 (0%) | 0% | 512.1 | 25,606 | Common Stock |
| United Therapeutics Corp | Jan Malcolm | Director | Sale of securities on an exchange or to another person at price $ 482.98 per share. | 11 Dec 2025 | 50 | 470 (0%) | 0% | 483.0 | 24,149 | Common Stock |
| United Therapeutics Corp | Jan Malcolm | Director | Sale of securities on an exchange or to another person at price $ 400.29 per share. | 09 Sep 2025 | 700 | 520 (0%) | 0% | 400.3 | 280,203 | Common Stock |
| United Therapeutics Corp | Jan Malcolm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 1,830 | 1,830 | - | - | Stock Options | |
| United Therapeutics Corp | Jan Malcolm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 650 | 650 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Jan Malcolm | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2025 | 630 | 630 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Jan Malcolm | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2025 | 630 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Jan Malcolm | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2025 | 590 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Jan Malcolm | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2025 | 590 | 1,220 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Jan Malcolm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 1,440 | 1,440 | - | - | Stock Options | |
| United Therapeutics Corp | Jan Malcolm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 590 | 590 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Jan Malcolm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 1,520 | 1,520 | - | - | Stock Options | |
| United Therapeutics Corp | Jan Malcolm | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 630 | 630 | - | - | Restricted Stock Unit |